CX3CL1 and Alzheimer disease: However, a positive correlation between the plasma levels of soluble CX3CL1, and the course of AD and mild cognitive impairment has also been reported, providing an evidence for the involvement of soluble CX3CL1 in the pathogenesis of AD (Kim et al., 2008).